Please direct all media inquiries to Gina Cella at gcella@ataaction.org or 781-799-3137
Press Release
ATA AND ATA ACTION RESPOND TO DEA’S EXTENSION OF COVID-19 TELEMEDICINE FLEXIBILITIES FOR REMOTE PRESCRIBING OF CONTROLLED SUBSTANCES
WASHINGTON, DC, MAY 4, 2023 – The American Telemedicine Association (ATA) and ATA Action issued the following statement in response to the Drug Enforcement Administration’s (DEA) extension of COVID-19 telemedicine flexibilities for the remote prescription of...
ATA ACTION SUBMITS COMPREHENSIVE RECOMMENDATIONS TO DEA ON PROPOSED RULES REGARDING REMOTE PRESCRIBING OF CONTROLLED SUBSTANCES
WASHINGTON, DC, MARCH 29, 2023 – ATA Action officially submitted comprehensive comments regarding the Drug Enforcement Administration (DEA)’s proposed rules regarding the remote prescribing of controlled substances. In two letters to the DEA, ATA Action outlined...
MAJOR VOTE OF CONFIDENCE FOR TELEHEALTH WITH PRESIDENT BIDEN SIGNING OMNIBUS INTO LAW WITH TWO-YEAR EXTENSIONS FOR VIRTUAL CARE PROVISIONS
ATA and ATA ACTION Applaud Congress and the Administration, Renew Commitment to Seeking Permanency for Telehealth Services WASHINGTON, DC, JANUARY 3, 2023 – The American Telemedicine Association (ATA) and ATA Action issued the following statement, following...